Seegene to access BioServe’s repository of Indian DNA samples.



BioServe and Seegene inked a partnership to develop, validate, and service new test systems for a variety of infectious diseases in the Indian market.


Through this partnership, Seegene will access BioServe’s repository of Indian DNA samples to develop tools to test for illnesses such as sexually transmitted diseases, tuberculosis, and HIV.


BioServe will offer diagnostic testing services using Seegene’s Seeplex™ STD detection system for Mycoplasma hominis, Ureaplasma urealyticum, Neisseria gonorrhoeae, Chlamydia trachomatis, Herpes Simplex Virus 2, and HPV. All of the test systems are based on Seegene’s DPO™ technology.








This site uses Akismet to reduce spam. Learn how your comment data is processed.